These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6822746)

  • 1. Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.
    Seidenfeld SM; Cooper BH; Smith JW; Luby JP; Mackowiak PA
    J Infect Dis; 1983 Jan; 147(1):116-9. PubMed ID: 6822746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
    Lombardi G; Gramegna G; Cavanna C; Poma G; Marangoni E; Michelone G
    Mycopathologia; 1989 Apr; 106(1):31-4. PubMed ID: 2549421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
    Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B.
    Pfaller MA; Messer SA; Bolmström A
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):223-7. PubMed ID: 9884840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B.
    Prasad KN; Agarwal J; Dixit AK; Tiwari DP; Dhole TN; Ayyagari A
    Indian J Med Res; 1999 Jul; 110():11-7. PubMed ID: 10709333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan.
    Yang YL; Cheng MF; Wang CW; Wang AH; Cheng WT; Lo HJ; Hospitals T
    Med Mycol; 2010 Mar; 48(2):328-34. PubMed ID: 20141372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B.
    Anaissie E; Paetznick V; Proffitt R; Adler-Moore J; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):665-8. PubMed ID: 1748123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B.
    Dermoumi H
    Chemotherapy; 1992; 38(2):112-7. PubMed ID: 1591946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.